NASDAQ
According to Zyberno, TRANSCAT, INC. (TRNS) is not a buy — AVERAGE BUSINESS (53/100) with a negative Margin of Safety of -1.7% and a Brina Gap of -15.4% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, TRANSCAT, INC. (TRNS) trades at $85.85 against an estimated intrinsic value per share of $84.38 — a -1.7% Margin of Safety based on Owner Earnings of $25.36M TTM, projected at 46.4% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -15.4% weakens the case: based on the company's ROIC (1.7%) and reinvestment rate (1,010.2%), the business can fundamentally grow at 17.5% — but the current enterprise value implies the market expects 33.0%. This places TRNS in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 19.6% annually.
Over the trailing twelve months, TRNS generated $25.36M in Owner Earnings. Capital was deployed as follows: $1.86M returned via share buybacks, $14.68M invested in capital expenditures. Reinvestment rate: 1,010.2%. Owner Earnings have grown at 46.4% annually over the trailing five years using log-linear regression.